Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant	Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Fanconi anemia, Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, anemia, aplastic anemia, bone marrow disorder, familial hemolytic anemia, graft versus host disease, hematologic disorder, hemolytic anemia, hereditary disease, immune system disorder, inherited aplastic anemia, inherited hemoglobinopathy, metabolic disease, sickle cell disease, thalassemia	Active, not recruiting	Phase 2	2026-02-25		NCT03924401

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Aflac Cancer and Blood Disorders Center	1
Bristol-Myers Squibb	422
Emory University	393
Sickle Cell Transplant Advocacy & Research Alliance (STAR)	1
Thrasher Research Fund	11

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's of Alabama	Birmingham	United States	24
Childrens Healthcare of Atlanta	Atlanta	United States	2
Columbia University Irving Medical Center	New York	United States	234
Dana-Farber Cancer Institute	Boston	United States	626
Hackensack Meridian Health	Hackensack	United States	22
Nemours/Alfred I. duPont Hospital for Children	Wilmington	United States	7
Oishei Children's Hospital	Buffalo	United States	3
University of Mississippi Medical Center, Children's Center for Cancer and Blood Disorders	Jackson	United States	1